Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

• Cun-Liang Cai,
• Ming-Qiang Zhang,
• Jun Guo,
• Li-Wan Wang,
• Jing-Quan Zhao,
• Wen-Jia Guo,
• Xiang-Dong Mu,
• Yi Cui

Affiliations

Cun-Liang Cai

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Ming-Qiang Zhang

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Jun Guo

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Li-Wan Wang

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Jing-Quan Zhao

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Wen-Jia Guo

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Xiang-Dong Mu

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.

Yi Cui

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.